GLP-1 Players Seek to Differentiate in Increasingly Crowded Weight Loss Space
Media
Interview with Richard Yu, PhD Co-Founder & CEO, Abalone Bio
Interview
The promise and challenges of functionally active GPCR antibody drugs
Whitepaper
FAST: Enabling the rapid discovery and creation of GPCR agonist antibodies
Poster
